HRAS (G12C) NanoBRET Target Engagement Intracellular RAS Assay for screening of compounds binding to the target.
HRAS (G12C)
HRAS
HRAS1, RASH1
HEK293 human epithelial cell line from ATCC
384-well plate format using Promega’s NanoBRET TE Intracellular RAS Assay
HEK293 cells transiently expressing LgBiT®- HRAS(G12C) and SmBiT®- HRAS(G12C) Fusion Vectors were seeded into the wells of 384-well plates. The cells were pre-treated with the NanoBRET Tracer K-2 and then treated with reference compound BI-2852 for 2 hours. The BRET signal was measured on an Envision 2104 Multilabel Reader. IC50 value was calculated and IC50 curve was plotted using the GraphPad Prism program based on a sigmoidal dose response equation.
Binding of compound to target RAS
Compounds | IC50 (M) |
---|---|
BI-2852 | 6.234e-007 |
Malvern, PA, USA
More information can be found on our website RAS Assays for Drug Discovery
Reference compound IC50 for HRAS (G12C)